文献速递围术期管理与 ERAS

术中高氧治疗对心脏术后氧化应激及器官损伤的随机临床试验

Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2024-01-01

高氧组术中F2-异前列腺素和异呋喃平均高9.2 pg/mL(95%CI 1.0-17.4;P=0.03),但两组术后第2天血肌酐变化及急性肾损伤发生率(各21%)无差异,其他器官损伤结局亦未受影响。

要点

  • 心脏手术术中高氧较常氧增加术中氧化应激标志物。
  • 高氧未增加急性肾损伤,两组发生率均为21%。
  • 谵妄、心肌损伤、房颤及1年结局未见影响。

核心结论

  • 成人心脏手术中,术中高氧较常氧增加术中氧化应激,但未影响肾损伤及谵妄、心肌损伤、房颤等其他器官损伤指标。

研究设计与样本

  • 参与者与评估者双盲随机临床试验,2016年4月至2020年10月在一家三级医疗中心开展,随访1年。
  • 纳入年龄>18岁、无术前氧疗需求、急性冠脉综合征、颈动脉狭窄或透析的择期开放心脏手术成人患者。

主要发现

  • F2-异前列腺素和异呋喃从基线中位数73.3(53.1-101.1)pg/mL升至ICU入住时峰值85.5(64.0-109.8)pg/mL,高氧组术中平均高9.2 pg/mL(95%CI 1.0-17.4;P=0.03)。
  • 急性肾损伤两组各21例(21%)。
  • 术中氧疗未影响其他急性器官损伤、安全事件及1年肾脏、神经心理和功能结局。

关键数值与推荐

  • 高氧组FiO2为1.00,常氧组为维持血氧饱和度95%-97%的最低FiO2。

临床怎么用

  • 心脏手术中无需常规给予高氧,维持常氧即可,但本试验未显示高氧造成短期器官损伤。

局限性

  • 仅纳入择期开放心脏手术且无特定合并症的成人患者,外推受限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Liberal oxygen (hyperoxia) is commonly administered to patients during surgery, and oxygenation is known to impact mechanisms of perioperative organ injury. OBJECTIVE: To evaluate the effect of intraoperative hyperoxia compared to maintaining normoxia on oxidative stress, kidney injury, and other organ dysfunctions after cardiac surgery. DESIGN, SETTING, AND PARTICIPANTS: This was a participant- and assessor-blinded, randomized clinical trial conducted from April 2016 to October 2020 with 1 year of follow-up at a single tertiary care medical center. Adult patients (>18 years) presenting for elective open cardiac surgery without preoperative oxygen requirement, acute coronary syndrome, carotid stenosis, or dialysis were included. Of 3919 patients assessed, 2501 were considered eligible and 213 provided consent. Of these, 12 were excluded prior to randomization and 1 following randomization whose surgery was cancelled, leaving 100 participants in each group. INTERVENTIONS: Participants were randomly assigned to hyperoxia (1.00 fraction of inspired oxygen [FiO2]) or normoxia (minimum FiO2 to maintain oxygen saturation 95%-97%) throughout surgery. MAIN OUTCOMES AND MEASURES: Participants were assessed for oxidative stress by measuring F2-isoprostanes and isofurans, for acute kidney injury (AKI), and for delirium, myocardial injury, atrial fibrillation, and additional secondary outcomes. Participants were monitored for 1 year following surgery. RESULTS: Two hundred participants were studied (median [IQR] age, 66 [59-72] years; 140 male and 60 female; 82 [41.0%] with diabetes). F2-isoprostanes and isofurans (primary mechanistic end point) increased on average throughout surgery, from a median (IQR) of 73.3 (53.1-101.1) pg/mL at baseline to a peak of 85.5 (64.0-109.8) pg/mL at admission to the intensive care unit and were 9.2 pg/mL (95% CI, 1.0-17.4; P = .03) higher during surgery in patients assigned to hyperoxia. Median (IQR) change in serum creatinine (primary clinical end point) from baseline to postoperative day 2 was 0.01 mg/dL (-0.12 to 0.19) in participants assigned hyperoxia and -0.01 mg/dL (-0.16 to 0.19) in those assigned normoxia (median difference, 0.03; 95% CI, -0.04 to 0.10; P = .45). AKI occurred in 21 participants (21%) in each group. Intraoperative oxygen treatment did not affect additional acute organ injuries, safety events, or kidney, neuropsychological, and functional outcomes at 1 year. CONCLUSIONS: Among adults receiving cardiac surgery, intraoperative hyperoxia increased intraoperative oxidative stress compared to normoxia but did not affect kidney injury or additional measurements of organ injury including delirium, myocardial injury, and atrial fibrillation. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02361944.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Lopez MG, Shotwell MS, Hennessy C, et al. Intraoperative Oxygen Treatment, Oxidative Stress, and Organ Injury Following Cardiac Surgery: A Randomized Clinical Trial. JAMA Surg. 2024. PMID: 39110454. doi:10.1001/jamasurg.2024.2906

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。